Log In

Forgot Password?
Create New Account

Loading... please wait

Abstract Details

Calpain Activity and Expression Varies with Severity of Disease in Multiple Sclerosis
073
Authors/Disclosures
Audrey Leasure Ms. Leasure has nothing to disclose.
Anirudh Sreekrishnan (UCSF) Dr. Sreekrishnan has nothing to disclose.
No disclosure on file
No disclosure on file
No disclosure on file
Sonya E. Zhou, MD (Hospital of the University of Pennsylvania) Sonya Zhou has nothing to disclose.
David Y. Hwang, MD, FAAN (University of North Carolina School of Medicine) Dr. Hwang has received publishing royalties from a publication relating to health care. Dr. Hwang has a non-compensated relationship as a Board of Directors with Neurocritical Care Society that is relevant to AAN interests or activities.
Lauren H. Sansing, MD Dr. Sansing has nothing to disclose.
David M. Greer, MD, FAAN (Boston University School of Medicine) Dr. Greer has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Thieme, Inc. Dr. Greer has received personal compensation in the range of $5,000-$9,999 for serving as an Expert Witness for multiple. The institution of Dr. Greer has received research support from Becton, Dickinson and Company. Dr. Greer has received publishing royalties from a publication relating to health care. Dr. Greer has received publishing royalties from a publication relating to health care.
Kevin N. Sheth, MD, FAAN (Yale UniversityDivision of Neuro and Critical Care) Dr. Sheth has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Ceribell. Dr. Sheth has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Zoll. Dr. Sheth has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for NControl. Dr. Sheth has received stock or an ownership interest from Astrocyte. Dr. Sheth has received stock or an ownership interest from Alva. The institution of Dr. Sheth has received research support from Biogen. The institution of Dr. Sheth has received research support from Novartis. The institution of Dr. Sheth has received research support from Bard. The institution of Dr. Sheth has received research support from Hyperfine. Dr. Sheth has received intellectual property interests from a discovery or technology relating to health care.